Health
EU regulators move up Pfizer vaccine evaluation – Hong Kong Standard
Facing strong pressure from Germany and other European Union nations, the bloc’s medicines agency on Tuesday moved up a meeting to assess the Pfizer-BioNTech coronavirus…
Facing strong pressure from Germany and other European Union nations, the bloc’s medicines agency on Tuesday moved up a meeting to assess the Pfizer-BioNTech coronavirus vaccine to Dec. 21, likely bringing vaccinations a step closer for millions of EU citizens.
The agency said it made the decision after receiving additional data from the vaccine makers. The announcement came after Germany’s health minister and others had publicly demanded that the agency move quicker than its previously planned…
-
Business22 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News21 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General16 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News19 hours agoTips to improve engagement – Proctor